Atlassian Shorts Rebuild Into Earnings Eve
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
TEAM arrives at its October 29 earnings report with short sellers adding positions at the fastest weekly pace in over a month, even as the analyst community continues to raise price targets almost in unison.
Short interest has climbed to 5.67% of free float, up 7.7% over the past week to roughly 9.53 million shares. That is a meaningful acceleration. The prior note from October 21 documented a modest early-week rebound; since then, the rebuild has broadened, adding around 830,000 shares in just the past few days. The move reverses the September drift lower that took short interest from above 10 million shares to a mid-month trough near 8.65 million. Despite the rebuilding, the borrow market offers no friction. Cost to borrow has eased to 0.29%, down around 13% on the week and more than 40% over the past month. Availability is extraordinarily loose at over 9,300% of short interest, meaning 157 million shares remain available to lend against the roughly 9.5 million already borrowed. No squeeze dynamic is present.
Options positioning leans slightly toward calls. The put/call ratio of 0.73 is fractionally below its 20-day average of 0.75 and about 1.2 standard deviations below the mean on a z-score basis, near the less-defensive end of the past year's range. The 52-week high on the PCR is 1.43; the current reading is nowhere near that. Options traders are not crowding into protection ahead of the print.
The Street remains solidly constructive. Ten firms raised price targets over the past two weeks, all maintaining positive ratings. The consensus mean target is $227.55, a modest premium to the current $219.41 price. Oppenheimer moved furthest in dollar terms among recent movers, lifting its Outperform target to $275 from $200 on October 22. Guggenheim pushed its Buy target to $280 from $165 on October 19, the largest proportional move. Citi, BTIG, Truist and several others all raised in the same window. Bulls cite record large deals, 23% subscription ARR growth, 88.7% gross margins, and the early monetisation runway from AI tools including Rovo and Teamwork Graph. Bears point to slowing JSM growth, competitive pressure from ServiceNow at the enterprise end and newer entrants below, and the question of whether agentic AI adoption will proceed as quickly as pricing models assume. The price-to-earnings multiple is near 34x and has expanded about 5.8 points over the past 30 days, tracking the stock's 17% gain over the same period.
One potential mechanical catalyst sits further out. ORTEX puts the probability of Atlassian joining the Nasdaq-100 at 69% at the December 2026 Annual Review, with the rank date on November 30. At $55.5 billion in market cap, the stock is already 19.5% above the price that would flip the index rule in its favour. If added, the implied tracker buying flow is $3.1 billion, equivalent to roughly 3.6 days of normal volume. Past additions of a similar type saw the stock move a median of plus 2.1% from announcement to effective date, with 79% moving in the expected direction and trade-day volume running at 4.5 times normal. These are historical patterns, not a forecast for this case.
The co-founders Michael Cannon-Brookes and Scott Farquhar together hold around 22.7% of shares as last disclosed in May, unchanged in count terms. BlackRock added roughly 1.2 million shares through to September 30. GQG Partners, which appeared as a new 8.4% holder in May, filed in August showing a drop to 4.8% with zero shares owned, a notable exit from a position built only months earlier. Insider activity over the past 90 days has been light and skewed to planned sales: the Chief Accounting Officer filed two small sales under a 10b5-1 plan, totalling modest value at prices between $190 and $210.
The only prior earnings event in the history data, from August 2026, produced a one-day gain of 31.5% and a five-day move of 46.5%. That single data point illustrates the magnitude of moves this stock can produce around results, in either direction. With the report due after close tomorrow, the combination of rebuilding short interest, a loose borrow market, one-sided analyst optimism, and compressed options defensiveness frames what is now primarily a binary event rather than a positioning squeeze.
Stocks in this article
See the live data behind this article on ORTEX.
Open TEAM on ORTEX →How this article was generated
- Generated
- 28 Oct 2026, 20:16
- Data as of
- 28 Oct 2026, 20:15
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataIndex RebalancePrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.